Article
http://www.researchprotection.org/sharavTestimonyArmyMedDept020507.htm has moved to:
https://ahrp.org/testimonypresentations/armymeddept.php
Please click on the link above to visit this page, and adjust your bookmarks accordingly.
Similar Posts
Elliott Spitzer walks away from prosecuting coporate crimes
Elliott Spitzer walks away from prosecuting coporate crimes Sat, 25 Dec 2004 “After nearly three years of high-profile prosecutions of investment banks, mutual funds and insurance companies, Attorney General Eliot Spitzer of New York said yesterday that he is ready to cede those investigations to federal regulators.” Whatever Eliot Spitzer…
Meta-Analysis: Efficacy & Safety of Antidepressants for Children – Brit Medical Journal
Meta-Analysis: Efficacy & Safety of Antidepressants for Children – Brit Medical Journal Sat, 10 Apr 2004 As news of skyrocketing prescribing of antidepressants for children–especially in preschool children–hit the news waves around the world, a major meta-analysis of the 5 published pediatric antidepressant studies was published in the British Medical…
Bioethics: Dial ‘E’ for ethics
Bbioethicists are seizing the opportunity to expand their own marketability. The UK publication, NATURE, reports about the latest bioethics gimmick that has sprung up in California– ‘dial-an-ethicist’—at the Stanford Center for Biomedical Ethics.
Drug Companies Move Trials Outside the US
Drug Companies Move Trials Outside the US Tue, 17 May 2005 Unless the FDA cracks down by enforcing safety and scientific standards in clinical trials, the drug industry is moving its drug trials out of any regulatory oversight. USA Today reports that 50% of trials sponsored by Wyeth Pharmaceuticals were…
Associated Press: More Details about FDA Warning Strattera Associated with Suicide
Associated Press: More Details about FDA Warning Strattera Associated with Suicide Thu, 29 Sep 2005 On April 26, 2004, we wrote: “The Alliance for Human Research Protection is concerned that children who are prescribed the failed antidepressant, Strattera, may be exposed to undisclosed serious risks of harm. FDA’s-approved label states:…
Statement by Vera Hassner Sharav, President AHRP: 2/2/04 Press Briefing
THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) 142 West End Ave. Suite 28P, New York, NY 10023 Tel. No: 212-595-8974, Fax No: 212-595-9086 ***PRESS BRIEFING 2/2/04*** Statement by Vera Hassner Sharav, President, AHRP The Alliance for Human Research Protection is convening this press conference because we believe a fair and…